BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.2//EN BEGIN:VEVENT DESCRIPTION:On 9 February 2026\, the third and final stakeholder workshop f or the project &ldquo\;Strengthening of the National Health Technology Ass essment (HTA) Framework in Greece&rdquo\; will be convened by the European Commission&rsquo\;s Reform and Investment Task Force (SG REFORM) through its Technical Assistance and Information Exchange (TAIEX) instrument\, in collaboration with the Ministry of Health of Greece\, WHO/Europe and the W HO Office on Quality of Care and Patient Safety in Athens.Taking place in Athens\, the workshop will present the final versions of the updated metho ds and process guides. The guides were piloted during a national assessmen t of a new medicinal product\, with contributions from patient and clinica l experts. The workshop will provide an opportunity for peer learning from other leading HTA agencies from the WHO European Region including the Ita lian Medicines Agency (AIFA)\, the Italian National Agency for Regional He althcare Services (AGENAS) and the Portuguese National Institute of Pharma cy and Medicines (INFARMED). It will also initiate discussions on establis hing an HTA framework for medical devices and in vitro diagnostics in Gree ce.Throughout the project\, the revision of Greece&rsquo\;s HTA methods an d process guidance has been informed by continuous engagement with all rel evant stakeholders\, including patient representatives\, clinical experts\ , industry partners and academics. Input gathered through earlier workshop s and technical consultations has helped ensure that the updated guidance reflects a broad range of perspectives and practical experience. The updat ed national HTA framework for Greece is aligned with the European Union Re gulation (EU) \;2021/2282 on HTA and draws on practices used across th e WHO European Region. Its implementation is supported by an updated legal framework and amendments to national policies and systems. The framework aims to strengthen transparent\, consistent and evidence-informed decision -making within Greece&rsquo\;s health system.Meeting detailsThe meeting wi ll bring together a broad range of stakeholders including Greek government agencies\, patient advocacy groups\, industry associations\, academic ins titutions\, peer HTA agencies\, the European Commission\, the Organisation for Economic Co-operation and Development and WHO. The event will feature presentations\, moderated discussions and interactive sessions\, facilita ting dialogue and knowledge exchange among participants. \; DTEND;VALUE=DATE:20260210 DTSTAMP:20260404T103110Z DTSTART;VALUE=DATE:20260209 LOCATION:Greece\,Athens SEQUENCE:0 SUMMARY:Strengthening Greece’s health technology assessment system: closing stakeholder workshop in Athens UID:RFCALITEM639108954701100854 X-ALT-DESC;FMTTYPE=text/html:

On 9 February 2026\, the third and final st akeholder workshop for the project &ldquo\;Strengthening of the National H ealth Technology Assessment (HTA) Framework in Greece&rdquo\; will be conv ened by the European Commission&rsquo\;s Reform and Investment Task Force (SG REFORM) through its Technical Assistance and Information Exchange (TAI EX) instrument\, in collaboration with the Ministry of Health of Greece\, WHO/Europe and the WHO Office on Quality of Care and Patient Safety in Ath ens.

Taking place in Athens\, the workshop will present the final ve rsions of the updated methods and process guides. The guides were piloted during a national assessment of a new medicinal product\, with contributio ns from patient and clinical experts. The workshop will provide an opportu nity for peer learning from other leading HTA agencies from the WHO Europe an Region including the Italian Medicines Agency (AIFA)\, the Italian Nati onal Agency for Regional Healthcare Services (AGENAS) and the Portuguese N ational Institute of Pharmacy and Medicines (INFARMED). It will also initi ate discussions on establishing an HTA framework for medical devices and i n vitro diagnostics in Greece.

Throughout the project\, the revision of Greece&rsquo\;s HTA methods and process guidance has been informed by continuous engagement with all relevant stakeholders\, including patient r epresentatives\, clinical experts\, industry partners and academics. Input gathered through earlier workshops and technical consultations has helped ensure that the updated guidance reflects a broad range of perspectives a nd practical experience.

The updated national HTA framework for Gre ece is aligned with the European Union Regulation (EU) \;2021/2282 on HTA and draws on practices used across the WHO European Region. Its implem entation is supported by an updated legal framework and amendments to nati onal policies and systems. The framework aims to strengthen transparent\, consistent and evidence-informed decision-making within Greece&rsquo\;s he alth system.

Meeting details

The meeting will bring together a broad range of stakeholders including Greek government agencie s\, patient advocacy groups\, industry associations\, academic institution s\, peer HTA agencies\, the European Commission\, the Organisation for Eco nomic Co-operation and Development and WHO. The event will feature present ations\, moderated discussions and interactive sessions\, facilitating dia logue and knowledge exchange among participants. \;

END:VEVENT END:VCALENDAR